Estimation of efficacy and safety of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in recurrent or metastatic breast cancer patients

被引：0
|
作者：
Kang, S. S. [1 ]
Lee, H. [1 ]
Hur, M. [1 ]
Ko, S. [1 ]
Yoon, C. [1 ]
Kang, S. [1 ]
Roh, J. [2 ]
机构：
[1] Dankook Univ, Cheil Gen Hosp, Surg, Seoul, South Korea
[2] Dankook Univ, Cheil Gen Hosp, Med Oncol, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
368
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Elderly Patients with Metastatic Breast Cancer: A Meta-Analysis
    Li, Xin
    Kwon, Hyungju
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [42] Phase II study of a polyethoxylated castor oil-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum
    Lee, J.
    Park, S.
    Lim, H.
    Kwon, J.
    Kim, G.
    Song, C.
    Hong, J.
    Kim, C.
    Ahn, H.
    Ahn, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [43] Consistent efficacy and safety of gemcitabine-paclitaxel in patients with metastatic breast cancer: A retrospective comparison of East Asian and global studies
    Xu, Binghe
    Zhang, Xiao Qing
    Chi, Hai Dong
    Liu, Zhixin
    Quinlivan, Mitchell
    Orlando, Mauro
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (04) : 330 - 339
  • [44] Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: final results of the non-interventional study NABUCCO
    Potthoff, K.
    Nusch, A.
    Soeling, U.
    Hansen, R.
    Salat, C.
    Grebhardt, S.
    Marschner, N.
    ANNALS OF ONCOLOGY, 2016, 27
  • [45] Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: Final results of the non-interventional study NABUCCO
    Marschner, N.
    Potthoff, K.
    Salat, C.
    Soeling, U.
    Hansen, R.
    Grebhardt, S.
    Horde, J.
    Nusch, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 183 - 183
  • [46] A phase II study to evaluate the efficacy, safety and pharmacokinetics of DHP107 (Liporaxel®, oral paclitaxel) compared to IV paclitaxel in patients with recurrent or metastatic breast cancer: OPERA (NCT03326102)
    Pluard, Timothy J.
    Sharma, Priyanka
    Melisko, Michelle E.
    Vidula, Neelima
    Weng, David E.
    Skelton, Jane D.
    Yoon, Koung Eun
    Cho, Hyun Ju
    Rugo, Hope S.
    CANCER RESEARCH, 2020, 80 (04)
  • [47] Efficacy and safety of first-line bevacizumab combined with paclitaxel in 220 patients with metastatic breast cancer: The Hungarian AVAREG observational study
    Dank, Magdolna
    Budi, Laszlo
    Landherr, Laszlo
    Piko, Bela
    Mangel, Laszlo
    Erfan, Jozsef
    Cseh, Jozsef
    Ruzsa, Agnes
    Nagy, Andras
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [48] The efficacy and safety of paclitaxel injection concentrate for nano-dispersion (PICN) at two different doses versus paclitaxel albumin-stabilized nanoparticle formulation in subjects with metastatic breast cancer (MBC).
    Jain, Minish Mahendra
    Patil, Shekhar
    Pathak, Anand Bhaskarrao
    Deshmukh, Chetan Dilip
    Bhatt, Niraj
    Babu, K. Govind
    Haritha, Chiramana
    Bondarde, Shailesh Arjun
    Digumarti, Raghunadharao
    Bajpai, Jyoti
    Kumar, Ravi
    Gupte, Smita Uday
    Bakshi, Ashish Vijay
    Bhattacharyya, Gouri Shankar
    Patil, Poonam
    Subramanian, S.
    Vaid, Ashok K.
    Desai, Chirag Jyotiker
    Bapsy, P. P.
    Divekar, Ganesh
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] Phase I clinical trial to assess safety and efficacy of Oraxol, a novel oral paclitaxel chemotherapy agent, in patients with previously treated metastatic breast cancer
    Yu, Yunfang
    Wang, Ying
    Mao, Luhui
    Ye, Suiwen
    Lai, Xiuping
    Chen, Junyi
    Zhang, Yiwen
    Liu, Jieqiong
    Wu, Junyan
    Qin, Tao
    Yao, Herui
    MEDCOMM, 2025, 6 (03):
  • [50] Effect of race on the safety and efficacy outcomes of gemcitabine plus paclitaxel treated patients with metastatic breast cancer (MBC): Analyses from a phase III trial
    Wang, Y.
    Tai, D.
    Zhao, L.
    Gill, J.
    Obasaju, C. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345